Noevir Holdings Co (TSE:4928) EBIT per Share: 円289.91 (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4928 Noevir Holdings Co Ltd TSE:4928
79 GF Score
Price 円4,585.00
GF Value 円5,265.32
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Noevir Holdings Co EBIT per Share?

Noevir Holdings Co TSE:4928 -0.43% 79 EBIT per Share is 円289.91 as of Dec. 2025. GuruFocus rates TSE:4928 with a GF Score™ of 79/100 and a GF Value™ of 円5,265.32 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 1,586 Consumer Packaged Goods companies, Noevir Holdings Co ranks worse than 57.82% on this metric.

Noevir Holdings Co's EBIT per Share for the three months ended in Dec. 2025 was 円65.98. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was 円289.91.

During the past 12 months, the average EBIT per Share Growth Rate of Noevir Holdings Co was -8.20% per year. During the past 3 years, the average EBIT per Share Growth Rate was 3.10% per year. During the past 5 years, the average EBIT per Share Growth Rate was 7.50% per year. During the past 10 years, the average EBIT per Share Growth Rate was 3.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Noevir Holdings Co's EBIT per Share or its related term are showing as below:

TSE:4928' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -8.8   Med: 11   Max: 42.2
Current: 3.1

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Noevir Holdings Co was 42.20% per year. The lowest was -8.80% per year. And the median was 11.00% per year.

TSE:4928's 3-Year EBIT Growth Rate is ranked worse than
57.82% of 1586 companies
in the Consumer Packaged Goods industry
Industry Median: 6.9 vs TSE:4928: 3.10

Noevir Holdings Co's EBIT for the three months ended in Dec. 2025 was 円2,252 Mil.


Noevir Holdings Co  (TSE:4928) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.


Noevir Holdings Co EBIT per Share Related Terms


Noevir Holdings Co EBIT per Share Historical Data

* Premium members only.

The historical data trend for Noevir Holdings Co's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Noevir Holdings Co EBIT per Share Chart

Noevir Holdings Co Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
EBIT per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 250.64 296.23 322.84 334.52 324.34

Noevir Holdings Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 74.34 67.26 89.85 65.98 66.82
TSE:4928
79GF Score
Noevir Holdings Co Ltd TSE:4928
EBIT per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Noevir Holdings Co EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Noevir Holdings Co's EBIT per Share for the fiscal year that ended in Sep. 2025 is calculated as

EBIT per Share(A: Sep. 2025 )
=EBIT/Shares Outstanding (Diluted Average)
=11078/34.156
=324.34

Noevir Holdings Co's EBIT per Share for the quarter that ended in Dec. 2025 is calculated as

EBIT per Share(Q: Dec. 2025 )
=EBIT/Shares Outstanding (Diluted Average)
=2252/34.134
=65.98

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円289.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT per Share →
What does a EBIT per Share of 円289.91 mean?
Noevir Holdings Co (TSE:4928) has a EBIT per Share of 円289.91 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Noevir Holdings Co and its competitors. According to the industry distribution chart, Noevir Holdings Co ranks #917 out of 1586 companies in the Consumer Packaged Goods industry, placing it in the top 57.8%.
Is Noevir Holdings Co's EBIT per Share too high?
Noevir Holdings Co's current EBIT per Share is 円289.91. Based on the distribution chart, Noevir Holdings Co ranks #917 out of 1586 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, Noevir Holdings Co has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Noevir Holdings Co's EBIT per Share compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Noevir Holdings Co ranks #917 out of 1586 companies for EBIT per Share. This places Noevir Holdings Co in the lower half of its industry. The industry median EBIT per Share is 6.90. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Consumer Packaged Goods company?
The median EBIT per Share among Consumer Packaged Goods companies is 6.90, based on 1,586 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Noevir Holdings Co and its competitors. For the Consumer Packaged Goods industry, the median EBIT per Share is 6.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Noevir Holdings Co's current EBIT per Share is 円289.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Noevir Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Noevir Holdings Co (TSE:4928) is currently considered Modestly Undervalued. The stock's GF Value™ is 円5,265.32, compared to a current price of 円4,585.00 — trading 12.9% below its estimated fair value. The current EBIT per Share is 円289.91. Noevir Holdings Co's overall GF Score™ is 79/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Noevir Holdings Co (TSE:4928), the current EBIT per Share is 円289.91 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Noevir Holdings Co (TSE:4928) Overvalued in 2026?

Based on GuruFocus' analysis, Noevir Holdings Co stock appears to be undervalued. The current stock price of 円4,585.00 is trading 12.9% below its estimated GF Value™ of 円5,265.32. GuruFocus considers Noevir Holdings Co to be Modestly Undervalued.

Key valuation signals for TSE:4928:

  • EBIT per Share: 円289.91
  • GF Value™: 円5,265.32 vs. price of 円4,585.00 (12.9% below fair value)
  • GF Score™: 79/100 with 2 warning signs

No single metric tells the full story. See the TSE:4928 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Noevir Holdings Co Business Description

Address 13-1, Minatojima Nakamachi 6-chome, Chuo-ku, Kobe, JPN, 650-8521
Noevir Holdings Co Ltd is a Japan-based company that is principally engaged in two businesses: cosmetics and pharmaceuticals and health food. The cosmetics business produces and offers skincare and makeup products under a number of brands, like Noevir, NOV, and Sana. The pharmaceuticals and health food business develops, produces, and sells a broad range-of-products, including Nanten Nodo Ame cough drops, functional drinks, and other over-the-counter pharmaceuticals, such as cold remedies and eye drops, and health food products as well. These two businesses jointly contribute the majority of the company's revenue. The company also operates apparel and aircraft sales and leasing. The company has a presence in many countries across the world and focuses on developing Asian markets.
79GF Score

Get the complete analysis for TSE:4928

EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円4,585.00
Price
円5,265.32
GF Value